Ian Lai
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 3
- Protein Degradation and Inhibitors 1
- Circular RNAs in diseases 1
-
- Cancer, Lipids, and Metabolism 1
- Co-authors
- Dean W. Felsher (7 shared papers)Renumathy Dhanasekaran (4 shared papers)Virginie Baylot (3 shared papers)Adriane Mosley (3 shared papers)Meital Gabay (2 shared papers)Srividya Swaminathan (2 shared papers)Sibu Kuruvilla (2 shared papers)Nia Adeniji (2 shared papers)
- Journals
- Cancer Research (3 papers)eLife (2 papers)Journal for ImmunoTherapy of Cancer (1 paper)Oncotarget (1 paper)Cell chemical biology (1 paper)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Ian Lai
9 papers receiving 271 citations
Peers
Comparison fields: 5 of 46
- Cancer Research 69
- Immunology 83
- Oncology 79
- Hepatology 18
- Molecular Biology 159
Countries citing papers authored by Ian Lai
This map shows the geographic impact of Ian Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Lai more than expected).
Fields of papers citing papers by Ian Lai
This network shows the impact of papers produced by Ian Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Lai. The network helps show where Ian Lai may publish in the future.
Co-authors
The 25 scholars most cited alongside Ian Lai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 115 | |
| 2 | 2020 | 48 | |
| 3 | 2017 | 38 | |
| 4 | 2022 | 31 | |
| 5 | 2022 | 30 | |
| 6 | 2021 | 6 | |
| 7 | 2025 | 1 | |
| 8 | 2021 | 1 | |
| 9 | 2023 | 1 |
About Ian Lai
Ian Lai is a scholar working on Molecular Biology, Cancer Research, Immunology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 9 papers that have together received 271 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (3 papers), Immunotherapy and Immune Responses (2 papers), Cancer Mechanisms and Therapy (1 paper), Ferroptosis and cancer prognosis (1 paper), Protein Degradation and Inhibitors (1 paper), Cancer, Lipids, and Metabolism (1 paper), Circular RNAs in diseases (1 paper) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Cancer Research (69 citations), Immunology (83 citations), Oncology (79 citations), Hepatology (18 citations) and Molecular Biology (159 citations). Ian Lai has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Dean W. Felsher, Renumathy Dhanasekaran, Virginie Baylot, Adriane Mosley, Meital Gabay, Srividya Swaminathan, Sibu Kuruvilla, Nia Adeniji, Priya Karmali and Ling Tong. Their work appears in journals such as Cancer Research, eLife, Journal for ImmunoTherapy of Cancer, Oncotarget and Cell chemical biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.